Versant Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Versant Capital Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.5K	Hold	261	–	–	0.01%	1042
2026 Q1	$52.1K	Buy	261 +5	+2%	+$989	0.01%	1211
2025 Q4	$48.4K	Hold	256	–	–	0.01%	1111
2025 Q3	$45.3K	Hold	256	–	–	0.01%	1092
2025 Q2	$29.1K	Buy	+256	New	+$27.4K	﹤0.01%	1305
2023 Q3	–	Sell	-7	Closed	-$505	–	2003
2023 Q2	$505	Sell	7 -14	-67%	-$1.05K	﹤0.01%	1834
2023 Q1	$1.54K	Hold	21	–	–	﹤0.01%	1337
2022 Q4	$1.4K	Sell	21 -13	-38%	-$845	﹤0.01%	1230
2022 Q3	$2K	Buy	34 +23	+209%	+$1.35K	﹤0.01%	1093
2022 Q2	$1K	Hold	11	–	–	﹤0.01%	1296
2022 Q1	$1K	Sell	11 -7	-39%	-$508	﹤0.01%	1312
2021 Q4	$2K	Sell	18 -150	-89%	-$13.9K	﹤0.01%	1137
2021 Q3	$15K	Buy	+168	New	+$13K	0.01%	577
2020 Q1	–	Sell	-13	Closed	–	–	1514
2019 Q4	$0	Hold	13	–	–	﹤0.01%	1477
2019 Q3	$0	Buy	+13	New	+$816	﹤0.01%	1487

Other funds holding LGND

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

PWG

Portside Wealth Group Provo, Utah $858M AUM 26.82% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Versant Capital Management's LGND Position: Q2 2026 in Review

Versant Capital Management held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 261 shares worth $82.5K. The position accounts for 0.01% of the portfolio, ranked #1042.

Versant Capital Management first reported a position in LGND in Q3 2019 and has held it in 15 quarters since. 36 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Versant Capital Management held 261 shares of Ligand Pharmaceuticals worth $82.5K as of Q2 2026.
Versant Capital Management left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
Ligand Pharmaceuticals made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1042 holding.
Versant Capital Management first reported a position in Ligand Pharmaceuticals in Q3 2019 and has held it in 15 quarters since.
36 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.